05/08/2025
GLP-1 receptor agonists—such as Ozempic, Wegovy, and Mounjaro—were originally developed to manage type 2 diabetes, but their use has rapidly expanded due to their ability to suppress appetite and promote weight loss. As an eating disorder therapist, I see both the potential and the pitfalls of t...
